Elevated glycosphingolipid (particularly Gb3) in the glycosphingolipid-enriched microdomains (GEMs) of the cancer cell membrane due to increased glucosylceramide synthase (GCS) activated the cSrc/β-catenin signaling pathway which upregulated the METTL3 expression. The gene discussed is UGCG; the disease is cancer.